A 28-year-old woman with a history of two spontaneous second-trimester miscarriages presents with a 6 cm DVT in the left popliteal vein. Activated partial thromboplastin time (aPTT) is prolonged and does not correct with 1:1 mixing study. Anticardiolipin antibodies and anti-β2-glycoprotein-I antibodies are positive. What is the most appropriate immediate next step in management?

Question

Accepted Answer

D. Initiate unfractionated heparin (UFH) or low-molecular-weight heparin (LMWH) and bridge to warfarin with target INR 3–4. ## Clinical Diagnosis This patient has **Antiphospholipid Syndrome (APS)** with thrombosis and obstetric manifestations (recurrent miscarriages). The prolonged aPTT that does NOT correct on mixing study (in vivo inhibitor) and positive anticardiolipin/anti-β2GP-I antibodies confirm the diagnosis. ### Antiphospholipid Syndrome Classification | Feature | Finding | Significance | |---------|---------|---------------| | Thrombotic event | DVT present | Meets criteria | | Obstetric manifestation | 2 second-trimester losses | Meets criteria | | Serologic markers | Anticardiolipin + anti-β2GP-I | Meets criteria | | **Diagnosis** | **Definite APS** | **High-risk thrombophilia** | ## Management Algorithm for APS with Thrombosis ```mermaid flowchart TD A[APS with acute thrombosis]:::outcome --> B[Acute anticoagulation]:::action B --> C[UFH or LMWH]:::action C --> D{High-risk APS?}:::decision D -->|Yes
Triple-positive or thrombosis| E[Warfarin INR 3-4]:::action D -->|No
Single-positive| F[Warfarin INR 2-3]:::action E --> G[Long-term anticoagulation]:::action F --> G ``` ## Key Point: **High-risk APS (triple-positive: lupus anticoagulant + anticardiolipin + anti-β2GP-I) with thrombosis requires higher-intensity anticoagulation: warfarin INR 3–4, NOT 2–3.** Standard INR 2–3 is insufficient and associated with recurrent thrombosis. ## High-Yield Facts: - **Lupus anticoagulant** (prolonged aPTT not correcting on mixing) is the most thrombogenic marker in APS. - **Triple-positive APS** (all three serologic markers present) is considered "high-risk" and requires INR 3–4. - **Warfarin monotherapy is contraindicated as initial therapy** — must bridge with heparin to avoid warfarin-induced skin necrosis (protein C depletion). - **Pregnancy in APS** requires LMWH + low-dose aspirin (not warfarin due to teratogenicity). ## Clinical Pearl: APS is a **prothrombotic state masquerading as a coagulopathy** — the prolonged aPTT reflects an in vivo inhibitor (lupus anticoagulant), not a factor deficiency. Mixing study fails to correct because the inhibitor persists in the mixture. This patient is at extremely high risk for recurrent thrombosis and requires aggressive anticoagulation.

Answer

A. Start warfarin monotherapy and aim for INR 2–3

Answer

B. Perform thrombophilia screening and defer anticoagulation until results are available

Answer

C. Initiate unfractionated heparin (UFH) or low-molecular-weight heparin (LMWH) and bridge to warfarin with target INR 2–3

Explanation

Clinical Diagnosis

Antiphospholipid Syndrome Classification

Management Algorithm for APS with Thrombosis

Key Point:

High-Yield Facts:

Clinical Pearl:

Practice similar questions

Join our NEET PG community